Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP309616.RAECRfcy-izfbXm60QhLtu8NL3tvFywL05W5G6c1Z7ZXM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP309616.RAECRfcy-izfbXm60QhLtu8NL3tvFywL05W5G6c1Z7ZXM130_assertion type Assertion NP309616.RAECRfcy-izfbXm60QhLtu8NL3tvFywL05W5G6c1Z7ZXM130_head.
- NP309616.RAECRfcy-izfbXm60QhLtu8NL3tvFywL05W5G6c1Z7ZXM130_assertion description "[Here, treatment with the novel LSD1 antagonist SP2509 attenuated the binding of LSD1 with the corepressor CoREST, increased the permissive H3K4Me3 mark on the target gene promoters, and increased the levels of p21, p27 and CCAAT/enhancer binding protein ? in cultured AML cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309616.RAECRfcy-izfbXm60QhLtu8NL3tvFywL05W5G6c1Z7ZXM130_provenance.
- NP309616.RAECRfcy-izfbXm60QhLtu8NL3tvFywL05W5G6c1Z7ZXM130_assertion evidence source_evidence_literature NP309616.RAECRfcy-izfbXm60QhLtu8NL3tvFywL05W5G6c1Z7ZXM130_provenance.
- NP309616.RAECRfcy-izfbXm60QhLtu8NL3tvFywL05W5G6c1Z7ZXM130_assertion SIO_000772 24699304 NP309616.RAECRfcy-izfbXm60QhLtu8NL3tvFywL05W5G6c1Z7ZXM130_provenance.
- NP309616.RAECRfcy-izfbXm60QhLtu8NL3tvFywL05W5G6c1Z7ZXM130_assertion wasDerivedFrom befree-20150227 NP309616.RAECRfcy-izfbXm60QhLtu8NL3tvFywL05W5G6c1Z7ZXM130_provenance.
- NP309616.RAECRfcy-izfbXm60QhLtu8NL3tvFywL05W5G6c1Z7ZXM130_assertion wasGeneratedBy ECO_0000203 NP309616.RAECRfcy-izfbXm60QhLtu8NL3tvFywL05W5G6c1Z7ZXM130_provenance.